ALPHA GRP. INTERNATIONAL ORD 0.2P overview

Alpha to Announce Fourth Quarter and Full Year 2024 Financial Results on February 28 PR Newswire BRISTOL, Tenn., Jan. 23, 2025 BRISTOL, Tenn. , Jan. 23, 2025 /PRNewswire/ --Alpha Metallurgical Resources, Inc. (NYSE: AMR), a leading U.S. supplier of metallurgical products for the steel industry, plans to announce its fourth quarter and full year 2024 financial results before the market opens on Friday, February 28, 2025 . The company also expects to hold a conference call to discuss its fourth...

Alpha and Omega Semiconductor Limited ("AOS") (Nasdaq: AOSL) today announced that the company will release its financial results for the fiscal second quarter ended December 31, 2024 on Wednesday, February 5, 2025, after the market closes. The press release will be followed by a conference call and live webcast at 2:00 p.m. PT / 5:00 p.m. ET, which will be open to the public. During the conference call, the company will review the financial results and discuss other business matters. To listen...

Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today announced the strategic appointments of Jen Pesa , Vice President of Commercial; Jack Kelly , Head of Market Access; Rommel Fernandez , Vice President of Corporate Strategy and Operations; and Kurt Grady , Vice President of Medical Affairs. These hires mark significant milestones in building...

Alpha and Omega Semiconductor Limited ("AOS") (Nasdaq: AOSL) today announced that company management is scheduled to participate in the 27 th Annual Needham Growth Conference on January 15, 2025, at the Lotte New York Palace Hotel, New York, NY. Management will be available for one-on-one meetings with institutional investors. Portfolio managers and analysts who wish to request a meeting should contact their Needham institutional sales representative. About Alpha and Omega Semiconductor Alpha...

Alpha Cognition, Inc. (Nasdaq: ACOG) (“ACI” or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, and China Medical System Holdings Limited (CMS) (867.HK), a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability in the People’s Republic of China, today announced an exclusive licensing agreement for the development, manufacturing and...

Alpha and Omega Semiconductor Limited (AOS) (Nasdaq: AOSL), a designer, developer, and global supplier of a broad range of discrete power devices, wide bandgap power devices, power management ICs, and modules, today unveiled its AOZ73016QI , a 16-Phase, 2-rail controller specifically designed to the latest OpenVReg16 (OVR16) specifications from NVIDIA. The AOZ73016QI controller design is based on the company’s high performance, proprietary AOS Advanced Transient Modulator (A 2 TM) control...

Moomoo Announces Global Partnership With Seeking Alpha to Amplify Trading Potential for Investors PR Newswire JERSEY CITY, N.J., Jan. 7, 2025 JERSEY CITY, N.J. , Jan. 7, 2025 /PRNewswire/ -- Moomoo, one of the world's leading investment and trading platforms, today announced its partnership with Seeking Alpha, a leading financial research platform powered by one of the world's largest investing communities. Through the strategic partnership, the two platforms aim to empower global investors with...

Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today announced it will host an investor update call on Tuesday, January 28 th , 2025 at 4pm EST to present its commercial launch strategy for ZUNVEYL (benzgalantamine), an FDA-approved treatment for mild-to-moderate Alzheimer’s disease (AD). The call will focus on the company’s plans to address...